Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.620
+0.170 (3.82%)
Jan 17, 2025, 4:00 PM EST - Market closed
Camp4 Therapeutics Employees
Camp4 Therapeutics had 64 employees as of December 31, 2023.
Employees
64
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$804,719
Market Cap
93.14M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 64 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
CAMP News
- 4 months ago - Genetic disease biotech CAMP4 Therapeutics files for a $75 million IPO - Renaissance Capital
- 4 months ago - Kaiser Permanente-backed biopharma CAMP4 files for US IPO - Reuters
- 4 months ago - CAMP4 Therapeutics IPO Registration Document (S-1) - SEC
- 4 months ago - CAMP4 Therapeutics Secures Orphan Drug Designation for CMP-CPS-001 for the Treatment of Urea Cycle Disorders - GLOBE NEWSWIRE